Bio-Rad Laboratories
Search results
The cell's a big place—now go eXplore it with the precision of high-plex single cell spatial imaging. Map more cell types and pathways with 5,000 genes, use enhanced cell segmentation to guide your way, and get rapid insights with visualizable data at the end of a run. See performance.
We deliver powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 7,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.
Technology - 10x Genomics. An innovative solution for robust, scalable single cell analysis. Chromium instruments are powered by Next GEM technology. Download Chromium Technology Brochure. Next GEM technology is built on a novel chip architecture that enables high-throughput single cell analysis with our Chromium instruments.
10x Genomics, Inc. is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness.
5 days ago · Investor Relations. We are a life science technology company building products to interrogate, understand and master biology. Our integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology.
Jun 20, 2024 · About 10x Genomics 10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health.
Get the latest 10X Genomics Inc (TXG) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Feb 5, 2024 · 10x Genomics will share new capabilities for its Chromium Flex assay, including: Whole blood fixation to directly fix whole blood for storage and later use with the Flex assay. Intracellular...
Jul 10, 2024 · 10x Genomics' share price is down nearly 15% today and >70% year-to-date. The company offers innovative products for biological analysis but faces heavy losses and declining revenues of key products.
Feb 7, 2024 · 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the launch of GEM-X, the next generation of the company's leading single cell technology.
